Legius Syndrome and its Relationship with Neurofibromatosis Type 1

被引:10
作者
Denayer, Ellen [1 ]
Legius, Eric [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium
关键词
CAL; NF1; Legius syndrome; SPRED1; SPRED1; MUTATIONS; GERMLINE MUTATIONS; SCHWANN-CELLS; GENE; GENOTYPE; PHENOTYPE; SUPPRESSOR; DELETION; CANCER; NOONAN;
D O I
10.2340/00015555-3429
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Neurofibromatosis type 1 (NF1) is the most common disorder characterized by multiple cafe-au-lait macules. Most individuals with this autosomal dominant disorder also have other features, such as skinfold freckling, iris Lisch nodules and benign or malignant peripheral nerve sheath tumours. Legius syndrome is a less frequent autosomal dominant disorder with similar multiple cafe-au-lait macules and skinfold freckling. Legius syndrome is not characterized by an increased risk of tumours, and a correct diagnosis is important. In young children with a sporadic form of multiple cafe-au-lait macules with or without freckling and no other manifestations of NF1 these 2 conditions cannot be differentiated based on clinical examination. Molecular analysis of the NF1 and SPRED1 genes is usually needed to differentiate the 2 conditions. Other less frequent conditions with cafe-au-lait macules are Noonan syndrome with multiple lentigines, constitutional mismatch repair deficiency and McCune-Albright syndrome.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 44 条
  • [21] Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
    Koczkowska, Magdalena
    Chen, Yunjia
    Callens, Tom
    Gomes, Alicia
    Sharp, Angela
    Johnson, Sherrell
    Hsiao, Meng-Chang
    Chen, Zhenbin
    Balasubramanian, Meena
    Barnett, Christopher P.
    Becker, Troy A.
    Ben-Shachar, Shay
    Bertola, Debora R.
    Blakeley, Jaishri O.
    Burkitt-Wright, Emma M. M.
    Callaway, Alison
    Crenshaw, Melissa
    Cunha, Karin S.
    Cunningham, Mitch
    D'Agostino, Maria D.
    Dahan, Karin
    De Luca, Alessandro
    Destree, Anne
    Dhamija, Radhika
    Eoli, Marica
    Evans, D. Gareth R.
    Galvin-Parton, Patricia
    George-Abraham, Jaya K.
    Gripp, Karen W.
    Guevara-Campos, Jose
    Hanchard, Neil A.
    Hernandez-Chico, Concepcion
    Immken, LaDonna
    Janssens, Sandra
    Jones, Kristi J.
    Keena, Beth A.
    Kochhar, Aaina
    Liebelt, Jan
    Martir-Negron, Arelis
    Mahoney, Maurice J.
    Maystadt, Isabelle
    McDougall, Carey
    McEntagart, Meriel
    Mendelsohn, Nancy
    Miller, David T.
    Mortier, Geert
    Morton, Jenny
    Pappas, John
    Plotkin, Scott R.
    Pond, Dinel
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 102 (01) : 69 - 87
  • [22] Cancer in Noonan, Costello, Cardiofaciocutaneous and LEOPARD Syndromes
    Kratz, Christian P.
    Rapisuwon, Suthee
    Reed, Helen
    Hasle, Henrik
    Rosenberg, Philip S.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2011, 157C (02) : 83 - 89
  • [23] SOMATIC DELETION OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN A NEUROFIBROSARCOMA SUPPORTS A TUMOR SUPPRESSOR GENE HYPOTHESIS
    LEGIUS, E
    MARCHUK, DA
    COLLINS, FS
    GLOVER, TW
    [J]. NATURE GENETICS, 1993, 3 (02) : 122 - 126
  • [24] Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion
    Marque, Myriam
    Roubertie, Agathe
    Jaussent, Audrey
    Carneiro, Maryline
    Meunier, Laurent
    Guillot, Bernard
    Pinson, Lucile
    Pinson, Stephane
    Bessis, Didier
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (05) : 768 - 775
  • [25] Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients
    Merker, Vanessa L.
    Esparza, Sonia
    Smith, Miriam J.
    Stemmer-Rachamimov, Anat
    Plotkin, Scott R.
    [J]. ONCOLOGIST, 2012, 17 (10) : 1317 - 1322
  • [26] Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome
    Messiaen, Ludwine
    Yao, Suxia
    Brems, Hilde
    Callens, Tom
    Sathienkijkanchai, Achara
    Denayer, Ellen
    Spencer, Emily
    Arn, Pamela
    Babovic-Vuksanovic, Dusica
    Bay, Carolyn
    Bobele, Gary
    Cohen, Bruce H.
    Escobar, Luis
    Eunpu, Deborah
    Grebe, Theresa
    Greenstein, Robert
    Hachen, Rachel
    Irons, Mira
    Kronn, David
    Lemire, Edmond
    Leppig, Kathleen
    Lim, Cynthia
    McDonald, Marie
    Narayanan, Vinodh
    Pearn, Amy
    Pedersen, Robert
    Powell, Berkley
    Shapiro, Lawrence R.
    Skidmore, David
    Tegay, David
    Thiese, Heidi
    Zackai, Elaine H.
    Vijzelaar, Raymon
    Taniguchi, Koji
    Ayada, Toranoshin
    Okamoto, Fuyuki
    Yoshimura, Akihiko
    Parret, Annabel
    Korf, Bruce
    Legius, Eric
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (19): : 2111 - 2118
  • [27] Health Supervision for Children With Neurofibromatosis Type 1
    Miller, David T.
    Freedenberg, Debra
    Schorry, Elizabeth
    Ullrich, Nicole J.
    Viskochil, David
    Korf, Bruce R.
    Chen, Emily
    Trotter, Tracy L.
    Berry, Susan A.
    Burke, Leah W.
    Geleske, Timothy A.
    Hamid, Rizwan
    Hopkin, Robert J.
    Introne, Wendy J.
    Lyons, Michael J.
    Scheuerle, Angela E.
    Stoler, Joan M.
    Freedenberg, Debra
    Jones, Marilyn C.
    [J]. PEDIATRICS, 2019, 143 (05)
  • [28] SPRED1 Mutations in a Neurofibromatosis Clinic
    Muram-Zborovski, Talia M.
    Stevenson, David A.
    Viskochil, David H.
    Dries, David C.
    Wilson, Andrew R.
    Mao, Rong
    [J]. JOURNAL OF CHILD NEUROLOGY, 2010, 25 (10) : 1203 - 1209
  • [29] SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia
    Pasmant, E.
    Gilbert-Dussardier, B.
    Petit, A.
    de Laval, B.
    Luscan, A.
    Gruber, A.
    Lapillonne, H.
    Deswarte, C.
    Goussard, P.
    Laurendeau, I.
    Uzan, B.
    Pflumio, F.
    Brizard, F.
    Vabres, P.
    Naguibneva, I.
    Fasola, S.
    Millot, F.
    Porteu, F.
    Vidaud, D.
    Landman-Parker, J.
    Ballerini, P.
    [J]. ONCOGENE, 2015, 34 (05) : 631 - 638
  • [30] SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype
    Pasmant, E.
    Sabbagh, A.
    Hanna, N.
    Masliah-Planchon, J.
    Jolly, E.
    Goussard, P.
    Ballerini, P.
    Cartault, F.
    Barbarot, S.
    Landman-Parker, J.
    Soufir, N.
    Parfait, B.
    Vidaud, M.
    Wolkenstein, P.
    Vidaud, D.
    France, R. N. F.
    [J]. JOURNAL OF MEDICAL GENETICS, 2009, 46 (07) : 425 - 430